Bulletin of Experimental Biology and Medicine

, Volume 46, Issue 5, pp 1389–1393 | Cite as

The effect of aseptic proliferative inflammation on the localization and growth of spontaneous tumors of the mammary glands in mice of the high-cancer C3HA strain

  • M. D. Podil'chak


Experiments were performed on 160 female mice of the highly cancerous strain C3HA with the so-called “milk factor”. These experiments were aimed at studying the effect of proliferative inflammation on the growth of cancer. This proliferative inflammatory process was induced by the injection of 0.3 ml of 10% emulsion of infusorial earth in peach oil. At the age of 5 months the same mice received a repeated injection of 0.3 ml of 10% emulsion of infusorial earth in peach oil into the same site. Experiments demonstrated that the inflammatory process considerably affected the localization and the time of appearance of the tumors of the mammary glands. The neoplasms most frequently occur in the mammary gland affected by the proliferative inflammatory process. These neoplasms appeared in younger mice in comparison with the analogous group of control animals. The author assumes that the foci of the cellular proliferation caused by the inflammatory process create favorable conditions for manifestation of pathogenicity of the virus causing spontaneous cancer of the mammary gland.


Public Health Mammary Gland Control Animal Inflammatory Process Favorable Condition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. [1]
    L. A. Zil'ber, Sovet. Med. 8, 34–35 (1947).Google Scholar
  2. [2]
    Idem. L. A. Zil'ber, The Basis of Immunity, Moscow (1948). In Russian.Google Scholar
  3. [3]
    Idem., Zhur. Mikrobiol., Epidemiol. i Immunobiol 10, 15–22 (1950).Google Scholar
  4. [4]
    E. E. Pogosiants, Biull. Eksptl. Biol. i Med. 12, 29–30 (1946).Google Scholar
  5. [5]
    Idem., Problems of Oncology, 6, 19–30 and 291–292 (1953).Google Scholar
  6. [6]
    I. V. Sokolova, Biull. Eksptl. Biol. i Med. 11, 57–60 (1952).Google Scholar
  7. [7]
    A. D. Timofeevskii, Med. Zhur. Ukrain. 4, 8–16 (1952).Google Scholar
  8. [8]
    Idem. A. D. Timofeevskii, Modern Teaching on the Causes of Malignant Disease, Moscow (1953). In Russian.Google Scholar
  9. [9]
    Idem. A. D. Timofeevskii, Problems of Experimental and Clinical Oncology, 5–15, Moscow (1952). In Russian.Google Scholar
  10. [10]
    Idem., Arch. Patol. 3, 13–26 (1954).Google Scholar
  11. [11]
    N. M. Turkevich, Med. Zhur. Ukrain. 2, 24–33 (1950).Google Scholar
  12. [12]
    Idem., Voprosy Onkol. 6, 64–70 (1955).Google Scholar
  13. [13]
    Idem. N. M. Turkevich, Proceedings of a Scientific Meeting on the Problem: “The Nervous System in Malignant Disease,” 15–16 Kiev (1955). In RussianGoogle Scholar
  14. [14]
    J. J. Bittner, Lancet Res. v. 4, 159–167 (1944).Google Scholar
  15. [15]
    Idem., v. 7, 741–745 (1947).Google Scholar
  16. [16]
    L. Dmochowski, Brit. J. Exper. Path. v. 26, 267–269 (1945).Google Scholar
  17. [17]
    P. Rous, J. G. Kidd, J. Exper. Med. v. 73, 365–390 (1941).Google Scholar

Copyright information

© Consultants Bureau, Inc. 1959

Authors and Affiliations

  • M. D. Podil'chak
    • 1
  1. 1.Department of Clinical Surgery of the L'vov Medical InstituteL'vovUSSR

Personalised recommendations